Apolipoprotein A-I: Structure-function relationships

Journal of Lipid Research

Volumn 41, Issue 6, 2000, Pages 853-872

  Frank, Philippe G ^a,b   Marcel, Yves L ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoprotein A I mutants; Cholesterol efflux; HDL; LCAT; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHOLESTEROL TRANSPORT; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN A-I; ENZYME ACTIVATION; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033920731     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (207)

1. Brewer, H. B., Jr., T. Fairwell, A. LaRue, R. Ronan, A. Houser, and T. J. Bronzert. 1978. The amino acid sequence of human apoA-I, an apolipoprotein isolated from high density lipoproteins. Biochem. Biophys. Res. Commun. 80: 623-630.
2. Breslow, J. L., D. Ross, J. McPherson, H. Williams, D. Kurnit, A. L. Nussbaum, S. K. Karathanasis, and V. I. Zannis. 1982. Isolation and characterization of cDNA clones for human apolipoprotein A-I. Proc. Natl. Acad. Sci. USA. 79: 6861-6865.
3. Shoulders, C. C., and F. E. Baralle. 1982. Isolation of the human HDL apoprotein AI gene. Nucleic Acids Res. 10: 4873-4882.
4. Cheung, P., and L. Chan. 1983. Nucleotide sequence of cloned cDNA of human apolipoprotein A-I. Nucleic Acids Res. 11: 3703-3715.
5. Law, S. W., G. Gray, and H. B. Brewer, Jr. 1983. cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I. Biochem. Biophys. Res. Commun. 112: 257-264.
6. Karathanasis, S. K., V. I. Zannis, and J. L. Breslow. 1983. Isolation and characterization of the human apolipoprotein A-I gene. Proc. Natl. Acad. Sci. USA. 80: 6147-6151.
7. Shoulders, C. C., A. R. Kornblihtt, B. S. Munro, and F. E. Baralle. 1983. Gene structure of human apolipoprotein AI. Nucleic Acids Res. 11: 2827-2837.
8. Li, W-H., M. Tanimura, C-C. Luo, S. Datta, and L. Chan. 1988. The apolipoprotein multigene family: biosynthesis, structure-function relationships, and evolution. J. Lipid Res. 245-271.
9. Fitch, W. M. 1977. Phylogenies constrained by the crossover process as illustrated by human hemoglobins and a thirteen-cycle, eleven-amino-acid repeat in human apolipoprotein A-I. Genetics. 86: 623-644.
10. McLachlan, A. D. 1977. Repeated helical pattern in apolipoprotein-A-I. Nature. 267: 465-466.
11. Segrest, J. P., D. W. Garber, C. G. Brouillette, S. C. Harvey, and G. M. Anantharamaiah. 1994. The amphipathic α helix: A multifunctional structural motif in plasma apolipoproteins. Adv. Protein Chem. 45: 303-369.
12. Collet, X., V. L. Marcel, N. Tremblay, C. Lazure, R. W. Milne, B. Perret, and P. K. Weech. 1997. Evolution of mammalian apolipoprotein A-I and conservation of antigenicity: Correlation with primary and secondary structure. J. Lipid Res. 38: 634-644.
13. Palgunachari, M. N., V. K. Mishra, S. Lund-Katz, M. C. Phillips, S. O. Adeyeye, S. Alluri, G. M. Anantharamaiah, and J. P. Segrest. 1996. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity-implications for HDL assembly. Arterioscler. Thromb. Vasc. Biol. 16: 328-338.
14. Mishra, V. K., M. N. Palgunachari, G. Datta, M. C. Phillips, S. Lund-Katz, S. O. Adeyeye, J. P. Segrest, and G. M. Anantharamaiah. 1998. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes. Biochemistry. 37: 10313-10324.
15. Gillotte, K. L., M. Zaiou, S. Lund-Katz, G. M. Anantharamaiah, P. Holvoet, A. Dhoest, M. N. Palgunachari, J. P. Segrest, K. H. Weisgraber, G. H. Rothblat, and M. C. Phillips. 1999. Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. J. Biol. Chem. 274: 2021-2028.
16. Pownall, H. J., Q. Pao, and J. B. Massey. 1985. Isolation and specificity of rat lecithin:cholesterol acyltransferase: comparison with the human enzyme using reassembled high-density lipoproteins containing ether analogs of phosphatidylcholine. Biochim. Biophys. Acta. 833: 456-462.
17. Golder-Novoselsky, E., A. V. Nichols, E. M. Rubin, and T. M. Forte. 1995. Human apo A-I in transgenic mice is more efficient in activating lecithin:cholesterol acyltransferase than mouse apo A-I. Biochim. Biophys. Acta. 1254: 217-220.
18. Januzzi, J. L., N. Azrolan, A. O'Connell, K. Aalto-Setälä, and J. L. Breslow. 1992. Characterization of the mouse apolipoprotein Apoa-1/Apoc-3 gene locus: Genomic, mRNA, and protein sequences with comparisons to other species. Genomics. 14: 1081-1088.
19. Vitello, L. B., and A. M. Scanu. 1976. Studies on human serum high density lipoproteins. Self-association of apolipoprotein A-I in aqueous solutions. J. Biol. Chem. 251: 1131-1136.
20. Edelstein, C., and A. M. Scanu. 1980. Effect of guanidine hydrochloride on the hydrodynamic and thermodynamic properties of human apolipopiotein A-I in solution. J. Biol. Chem. 255: 5747-5754.
21. Reijngoud, D. J., and M. C. Phillips. 1982. Mechanism of dissociation of human apolipoprotein A-I from complexes with dimyristoylphosphatidylcholine as studied by guanidine hydrochloride denaturation. Biochemistry. 21: 2969-2976.
22. Sparks, D. L., S. Lund-Katz, and M. C. Phillips. 1992. The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. J. Biol. Chem. 267: 25839-25847.
23. Tall, A. R., G. G. Shipley, and D. M. Small. 1976. Conformational and thermodynamic properties of apo A-I of human plasma high density lipoproteins. J. Biol. Chem. 251: 3749-3755.
24. Privalov, P. L., and N. N. Khechinashvili. 1974. A thermodynamic approach to the problem of stabilization of globular protein structure: a calorimetric study. J. Mol. Biol. 86: 665-684.
25. Pace, C. N., and K. E. Vanderburg. 1979. Determining globular protein stability: guanidine hydrochloride denaturation of myoglobin. Biochemistry. 18: 288-292.
26. Gursky, O., and D. Atkinson. 1996. Thermal unfolding of human high-density apolipoprotein A-I: implications for a lipid-free molten globular state. Proc. Natl. Acad. Sci. USA. 93: 2991-2995.
27. Rogers, D. P., L. M. Roberts, J. Lebowitz, G. Datta, G. M. Anantharamaiah, J. A. Engler, and C. G. Brouillette. 1998. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions. Biochemistry. 37: 11714-11725.
28. Castro, G. R., and C. J. Fielding. 1988. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry. 27: 25-29.
29. Barrans, A., B. Jaspard, R. Barbaras, H. Chap, B. Perret, and X. Collet. 1996. Pre-beta HDL: structure and metabolism. Biochim. Biophys. Acta. 1300: 73-85.
30. Roberts, L. M., M. J. Ray, T. W. Shih, E. Hayden, M. M. Reader, and C. G. Brouillette. 1997. Structural analysis of apolipoprotein A-I: Limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human apo A-I. Biochemistry. 36: 7615-7624.
31. Rogers, D. P., C. G. Brouillette, J. A. Engler, S. W. Tendian, L. Roberts, V. K. Mishra, G. M. Anantharamaiah, S. Lund-Katz, M. C. Phillips, and M. J. Ray. 1997. Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation. Biochemistry. 36: 288-300.
32. Davidson, W. S., K. Arnvig-McGuire, A. Kennedy, J. Kosman, T. L. Hazlett, and A. Jonas. 1999. Structural organization of the N-terminal domain of apolipoprotein A-I: studies of tryptophan mutants(dagger). Biochemistry. 38: 14387-14395.
33. Tricerri, M. A., A. K. Behling Agree, S. A. Sanchez, and A. Jonas. 1999. Cysteine mutations as sites for fluorescent labeling and probing of apolipoprotein A-I structure. Biochemistry. Unpublished results.
34. Chou, P. Y., and G. D. Fasman. 1978. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. 47: 45-148.
35. Garnier, J., D. J. Osguthorpe, and B. Robson. 1978. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 120: 97-120.
36. Brouillette, C. G., and G. M. Anantharamaiah. 1995. Structural models of human apolipoprotein A-I. Biochim. Biophys. Acta. 1256: 103-129.
37. Jonas, A., K. E. Kézdy, and J. H. Wald. 1989. Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J. Biol. Chem. 264: 4818-4824.
38. Brasseur, R., J. De Meutter, B. Vanloo, E. Goormaghtigh, J. M. Ruysschaert, and M. Rosseneu. 1990. Mode of assembly of amphipathic helical segments in model high-density lipoproteins. Biochim. Biophys. Acta. 1043: 245-252.
39. Sparks, D. L., M. C. Phillips, and S. Lund-Katz. 1992. The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. J. Biol. Chem. 267: 25830-25838.
40. Jonas, A., J. H. Wald, K. L. Toohill, E. S. Krul, and K. E. Kezdy. 1990. Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. J. Biol. Chem. 265: 22123-22129.
41. Tall, A. R., D. M. Small, R. J. Deckelbaum, and G. G. Shipley. 1977. Structure and thermodynamic properties of high density lipoprotein recombinants. J. Biol. Chem. 252: 4701-4711.
42. Pownall, H. J., J. B. Massey, S. K. Kusserow, and A. M. Gotto, Jr. 1978. Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human high density lipoproteins with phosphatidylcholines. Biochemistry. 17: 1183-1188.
43. Jonas A., and S. M. Drengler. 1980. Kinetics and mechanism of apolipoprotein A-I interaction with L-alpha-dimyristoylphosphatidylcholine vesicles. J. Biol. Chem. 255: 2190-2194.
44. Atkinson, D., H. M. Smith, J. Dickson, and J. P. Austin. 1976. Interaction of apoprotein from porcine high-density lipoprotein with dimyristoyl lecithin. 1. The structure of the complexes. Eur. J. Biochem. 64: 541-547.
45. Forte, T. M., A. V. Nichols, E. L. Gong, S. Lux, and R. I. Levy. 1971. Electron microscopic study on reassembly of plasma high density apoprotein with various lipids. Biochim. Biophys. Acta. 248: 381-386.
46. Matz, C. E., and A. Jonas. 1982. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257: 4535-4540.
47. Nichols, A. V., E. L. Gong, P. J. Blanche, and T. M. Forte. 1983. Characterization of discoidal complexes of phosphatidylcholine, apolipoprotein A-I and cholesterol by gradient gel electrophoresis. Biochim. Biophys. Acta. 750: 353-364.
48. Nichols, A. V., P. J. Blanche, E. L. Gong, V. G. Shore, and T. M. Forte. 1985. Molecular pathways in the transformation of model discoidal lipoprotein complexes induced by lecithin:cholesterol acyltransferase. Biochim. Biophys. Acta. 834: 285-300.
49. Jonas, A., K. E. Kezdy, M. I. Williams, and K. A. Rye. 1988. Lipid transfers between reconstituted high density lipoprotein complexes and low density lipoproteins: effects of plasma protein factors. J. Lipid Res. 29: 1349-1357.
50. Pittman, R. C., C. K. Glass, D. Atkinson, and D. M. Small. 1987. Synthetic high density lipoprotein particles. Application to studies of the apoprotein specificity for selective uptake of cholesterol esters. J. Biol. Chem. 262: 2435-2442.
51. Sparks, D. L., G. M. Anantharamaiah, J. P. Segrest, and M. C. Phillips. 1995. Effect of the cholesterol content of reconstituted LpA-I on lecithin:cholesterol acyltransferase activity. J. Biol. Chem. 270: 5151-5157.
52. Segrest, J. P., R. L. Jackson, J. D. Morrisett, and A. M. Gotto, Jr. 1974. A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett. 38: 247-258.
53. Collet, X., B. Perret, G. Simard, E. Raffai, and Y. L. Marcel. 1991. Differential effects of lecithin and cholesterol on the immunoreactivity and conformation of apolipoprotein A-I in high density lipoproteins. J. Biol. Chem. 266: 9145-9152.
54. Calabresi, L., Q-H. Meng, G. R. Castro, and Y. L. Marcel. 1993. Apolipoprotein A-I conformation in discoidal particles: evidence for alternate structures. Biochemistry. 32: 6477-6484.
55. Anantharamaiah, G. M., J. L. Jones, C. G. Brouillette, C. F. Schmidt, B. H. Chung, T. A. Hughes, A. S. Bhown, and J. P. Segrest. 1985. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine. J. Biol. Chem. 260: 10248-10255.
56. Chung, B. H., G. M. Anatharamaiah, C. G. Brouillette, T. Nishida, and J. P. Segrest. 1985. Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function. J. Biol. Chem. 260: 10256-10262.
57. Epand, R. M., W. K. Surewicz, D. W. Hughes, H. Mantsch, J. P. Segrest, T. M. Allen, and G. M. Anantharamaiah. 1989. Properties of lipid complexes with amphipathic helix-forming peptides. Role of distribution of peptide charges. J. Biol. Chem. 264: 4628-4635.
58. Lecompte, M. F., A. C. Bras, N. Dousset, I. Portas, R. Salvayre, and M. Ayrault-Jarrier. 1998. Binding steps of apolipoprotein A-I with phospholipid monolayers: adsorption and penetration. Biochemistry. 37: 16165-16171.
59. Corijn, J., R. Deleys, C. Labeur, B. Vanloo, L. Lins, R. Brasseur, J. Baert, J. M. Ruysschaert, and M. Rosseneu. 1993. Synthetic model peptides for apolipoproteins. II. Characterization of the discoidal complexes generated between phospholipids and synthetic model peptides for apolipoproteins. Biochim. Biophys. Acta. 1170: 8-16.
60. Lins, L., R. Brasseur, M. De Pauw, J. P. Van Biervliet, J. M. Ruysschaert, M. Rosseneu, and B. Vanloo. 1995. Helix helix interactions in reconstituted high-density lipoproteins. Biochim. Biophys. Acta. 1258: 10-18.
61. Frank, P. G., J. Bergeron, F. Emmanuel, J. P. Lavigne, D. L. Sparks, P. Denèfle, E. Rassart, and Y. L. Marcel. 1997. Deletion of central α-helices in human apolipoprotein A-I: effect on phospholipid association. Biochemistry. 36: 1798-1806.
62. Boguski, M. S., M. Freeman, N. A. Elshourbagy, J. M. Taylor, and J. I. Gordon. 1986. On computer-assisted analysis of biological sequences: proline punctuation, consensus sequences, and apolipoprotein repeats. J. Lipid Res. 27: 1011-1034.
63. Dalton, M. B., and J. B. Swaney. 1993. Structural and functional domains of apolipoprotein A-I within high density lipoproteins. J. Biol. Chem. 268: 19274-19283.
64. Bergeron, J., P. G. Frank, D. Scales, Q. H. Meng, G. Castro, and Y. L. Marcel. 1995. Apolipoprotein A-I conformation in reconstituted discoidal lipoproteins varying in phospholipid and cholesterol content. J. Biol. Chem. 270: 27429-27438.
65. Andrews, A. L., D. Atkinson, M. D. Barrat, E. G. Finer, H. Hauser, R. Henry, R. B. Leslie, N. L. Owens, M. C. Phillips, and R. N. Robertson. 1976. Interaction of apoprotein from porcine high-density lipoprotein with dimyristoyl lecithin. Eur. J. Biochem. 64: 549-563.
66. Brouillette, C. G., J. L. Jones, T. C. Ng, H. Kercret, B. H. Chung, and J. P. Segrest. 1984. Structural studies of apolipoprotein A-I/ phosphatidylcholine recombinants by high-field proton NMR, nondenaturing gradient gel electrophoresis, and electron microscopy. Biochemistry. 23: 359-367.
67. Nolte, R. T., and D. Atkinson. 1992. Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism. Biophys. J. 63: 1221-1239.
68. Phillips, J. C., W. Wriggers, Z. G. Li, A. Jonas, and K. Schulten. 1997. Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks. Biophys. J. 73: 2337-2346.
69. Borhani, D. W., J. A. Engler, and C. G. Brouillette. 1999. Crystallization of truncated human apolipoprotein A-I in a novel conformation. Acta. Crystallogr. D. Biol. Crystallogr. 55: 1578-1583.
70. Borhani, D. W., D. P. Rogers, J. A. Engler, and C. G. Brouillette. 1997. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc. Natl. Acad. Sci. USA. 94: 12291-12296.
71. Wilson, C., M. R. Wardell, K. H. Weisgraber, R. W. Mahley, and D. A. Agard. 1991. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science. 252: 1817-1822.
72. Breiter, D. R., M. R. Kanost, M. M. Benning, G. Wesenberg, J. H. Law, M. A. Wells, I. Rayment, and H. M. Holden. 1991. Molecular structure of an apolipoprotein determined at 2.5-A resolution. Biochemistry. 30: 603-608.
73. Wald, J. H., E. Goormaghtigh, J. De Meutter, J. M. Ruysschaert, and A. Jonas. 1990. Investigation of the lipid domains and apolipoprotein orientation in reconstituted high density lipoproteins by fluorescence and IR methods. J. Biol. Chem. 265: 20044-20050.
74. Koppaka, V., L. Silvestro, J. A. Engler, C. G. Brouillette, and P. H. Axelsen. 1999. The structure of human lipoprotein A-I. Evidence for the "belt" model. J. Biol. Chem. 274: 14541-14544.
75. Segrest, J. P., M. K. Jones, A. E. Klon, C. J. Sheldahl, M. Hellinger, H. De Loof, and S. C. Harvey. 1999. A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J Biol. Chem. 274: 31755-31758.
76. Jonas, A., A. Von Eckardstein, K. E. Kézdy, A. Steinmetz, and G. Assmann. 1991. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. J. Lipid Res. 32: 97-106.
77. Lindholm, E. M., J. K. Bielicki, L. K. Curtiss, E. M. Rubin, and T. M. Forte. 1998. Deletion of amino acids Glul46→Arg160 in human apolipoprotein A-I (ApoA-I Seattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid. Biochemistry. 37: 4863-4868.
78. Weisgraber, K. H., T. P. Bersot, R. W. Mahley, G. Franceschini, and C. R. Sirtori. 1980. A-I milano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. J. Clin. Invest. 66: 901-907.
79. Weisgraber, K. H., S. C. Rall, Jr., T. P. Bersot, R. W. Mahley, G. Franceschini, and C. R. Sirtori. 1983. Apolipoprotein A-I Milano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J. Biol. Chem. 258: 2508-2513.
80. Milano, associated with familial hypoalphalipoproteinemia. J. Clin. Invest. 91: 1445-1452.
81. Milano dimer. J. Biol. Chem. 269: 32168-32174.
82. Milano transgenic mice. J. Lipid Res. 38: 2314-2321.
83. Milano has reduced capacity, compared with wild-type apolipoprotein A-I, to recruit membrane cholesterol. Arterioscler. Thromb. Vasc. Biol. 17: 1637-1643.
84. Calabresi, L., G. Franceschini, A. Burkybile, and A. Jonas. 1997. Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer. Biochem. Biophys. Res. Commun. 232: 345-349.
85. Calabresi, L., G. Vecchio, F. Frigerio, L. Vavassori, C. R. Sirtori, and G. Franceschini. 1997. Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein A-I dimer: evidence for restricted particle size heterogeneity. Biochemistry. 36: 12428-12433.
86. Milano. Atherosclerosis. 136: 139-146.
87. Milano on aortic atherosclerosis in apolipoprotein E-deficient mice. Circulation. 97: 780-785.
88. Burgess, J. W., P. G. Frank, V. Franklin, P. Liang, D. C. McManus, M. Desforges, E. Rassart, and Y. L. Marcel. 1999. Deletion of the C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage. Biochemistry. 38: 14524-14533.
89. Durbin, D. M., and A. Jonas. 1997. The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle. J. Biol. Chem. 272: 31333-31339.
90. McManus, D. C., P. G. Frank, V. Franklin, and Y. L. Marcel. 2000. Distinct central amphipathic helices in apolipoprotein A-I contribute to the in vivo maturation of HDL by either activating LCAT or binding lipids. J. Biol. Chem. 275: 5043-5051.
91. Funke, H., A. Von Eckardstein, P. H. Pritchard, M. Karas, J. J. Albers, G. Assmann, A. Reckwerth, and S. Welp. 1991. A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin:cholesterol-acyltransferase deficiency, and corneal opacities. J. Clin. Invest. 87: 371-376.
92. Strobl, W., H. U. Jabs, M. Hayde, T. Holzinger, G. Assmann, and K. Widhalm. 1988. Apolipoprotein A-I (Glu198(Lys): a mutant of the major apolipoprotein of high-density lipoproteins occurring in a family with dyslipoproteinemia. Pediatric Res. 24: 222-228.
93. Von Eckardstein, A., G. Castro, I. Wybranska, N. Theret, P. Duchateau, N. Duverger, J-C. Fruchart, G. Ailhaud, and G. Assmann. 1993. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with marine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by ApoA-I(Pro165Arg). J. Biol. Chem. 268: 2616-2622.
94. Han, H., J. Sasaki, A. Matsunaga, H. Hakamata, W. Huang, M. Ageta, T. Taguchi, T. Koga, M. Kugi, S. Horiuchi, and K. Arakawa. 1999. A novel mutant, ApoA-I nichinan (Glu235(0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells. Arterioscler. Thromb. Vasc. Biol. 19: 1447-1455.
95. Schmidt, H. H., A. T. Remaley, J. A. Stonik, R. Ronan, A. Wellmann, F. Thomas, L. A. Zech, H. B. Brewer, Jr., and J. M. Hoeg. 1995. Carboxyl-terminal domain truncation alters apolipoprotein A-I in vivo catabolism. J. Biol. Chem. 270: 5469-5475.
96. Holvoet, P., Z. Zhao, E. Deridder, A. Dhoest, and D. Collen. 1996. Effects of deletion of the carboxyl-terminal domain of ApoA-I or of its substitution with helices of ApoA-II on in vitro and in vivo lipoprotein association. J. Biol. Chem. 271: 19395-19401.
97. Holvoet, P., S. Danloy, and D. Collen. 1997. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism - a study based on deletion and substitution variants in transgenic mice. Eur. J. Biochem. 245: 642-647.
98. Laccotripe, M., S. C. Makrides, A. Jonas, and V. I. Zannis. 1997. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein. J. Biol. Chem. 272: 17511-17522.
99. Ji, Y., and A. Jonas. 1995. Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins. J. Biol. Chem. 270: 11290-11297.
100. Rogers, D. P., L. M. Roberts, J. Lebowitz, J. A. Engler, and C. G. Brouillette. 1998. Structural analysis of apolipoprotein A-I -Effects of amino- and carboxy-terminal deletions on the lipid-free structure. Biochemistry. 37: 945-955.
101. Fidge, N. H. 1999. High density lipoprotein receptors, binding proteins, and ligands. J. Lipid Res. 40: 187-201.
102. Oram, J. F., and S. Yokoyama. 1996. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37: 2473-2491.
103. Yokoyama, S. 1998. Apolipoprotein-mediated cellular cholesterol efflux. Biochim. Biophys. Acta 1392: 1-15.
104. Rothblat, G. H., M. Bamberger, and M. C. Phillips. 1986. Reverse cholesterol transport. Methods Enzymol. 129: 628-644.
105. Mahlberg, F. H., and G. H. Rothblat. 1992. Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs. J. Biol. Chem. 267: 4541-4550.
106. Li, Q., A. Komaba, and S. Yokoyama. 1993. Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells. Biochemistry. 32: 4597-4603.
107. Schroeder, F., J. R. Jefferson, A. B. Kier, J. Knittel, T. J. Scallen, W. G. Wood, and I. Hapala. 1991. Membrane cholesterol dynamics: cholesterol domains and kinetic pools. Proc. Soc. Exp. Biol. Med. 196: 235-252.
108. Rothblat, G. H., F. H. Mahlberg, W. J. Johnson, and M. C. Phillips. 1992. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J. Lipid Res. 33: 1091-1097.
109. Fournier, N., M. D. Moya, B. F. Burkey, J. B. Swaney, J. Paterniti, Jr., N. Moatti, V. Atger, and G. H. Rothblat. 1996. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J. Lipid Res. 37: 1704-1711.
110. Zhao, Y. W., D. L. Sparks, and Y. L. Marcel. 1996. Specific phospholipid association with apolipoprotein A-I stimulates cholesterol efflux from human fibroblasts - studies with reconstituted sonicated lipoproteins. J. Biol. Chem. 271: 25145-25151.
111. Johnson, W. J., M. J. Bamberger, R. A. Latta, P. E. Rapp, M. C. Phillips, and G. H. Rothblat. 1986. The bidirectional flux of cholesterol between cells and lipoproteins. Effects of phospholipid depletion of high density lipoprotein. J. Biol. Chem. 261: 5766-5776.
112. Johnson, W. J., F. H. Mahlberg, G. K. Chacko, M. C. Phillips, and G. H. Rothblat. 1988. The influence of cellular and lipoprotein cholesterol contents on the flux of cholesterol between fibroblasts and high density lipoprotein. J. Biol. Chem. 263: 14099-14106.
113. Brinton, E. A., J. F. Oram, C. H. Chen, J. J. Albers, and E. L. Bierman. 1986. Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues. J. Biol. Chem. 261: 495-503.
114. Mendez, A. J., and J. F. Oram. 1997. Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux. Biochim. Biophys. Acta 1346: 285-299.
115. Davidson, W. S., S. Lund-Katz, W. J. Johnson, G. M. Anantharamaiah, M. N. Palgunachari, J. P. Segrest, G. H. Rothblat, and M. C. Phillips. 1994. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. J. Biol. Chem. 269: 22975-22982.
116. Banka, C. L., A. S. Black, and L. K. Curtiss. 1994. Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. J. Biol. Chem. 269: 10288-10297.
117. Fielding, P. E., M. Kawano, A. L. Catapano, A. Zoppo, S. Marcovina, and C. J. Fielding. 1994. Unique epitope of apolipoprotein A-I expressed in pre-β-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. Biochemistry. 33: 6981-6985.
118. Luchoomun, J., N. Theret, V. Clavey, P. Duchateau, M. Rosseneu, R. Brasseur, P. Denefle, J. C. Fruchart, and G. R. Castro. 1994. Structural domain of apolipoprotein A-I involved in its interaction with cells. Biochim. Biophys. Acta. 1212: 319-326.
119. Sviridov, D., L. Pyle, and N. Fidge. 1996. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles. Biochemistry. 35: 189-196.
120. Meng, Q. H., J. Bergeron, D. L. Sparks, and Y. L. Marcel. 1995. Role of apolipoprotein A-I in cholesterol transfer between lipoproteins. Evidence for involvement of specific apoA-I domains. J. Biol. Chem. 270: 8588-8596.
121. Gillotte, K. L., W. S. Davidson, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips. 1996. Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux. J. Biol. Chem. 271: 23792-23798.
122. Sviridov, D., L. E. Pyle, and N. Fidge. 1996. Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants. J. Biol. Chem. 271: 33277-33283.
123. Frank, P. G., D. N'Guyen, V. Franklin, T. Neville, M. Desforges, E. Rassart, D. L. Sparks, and Y. L. Marcel. 1998. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins. Biochemistry. 37: 13902-13909.
124. Mendez, A. J. 1997. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J. Lipid Res. 38: 1807-1821.
125. Ji, Y., B. Jian, N. Wang, Y. Sun, M. D. Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982-20985.
126. Jian, B., M. De la Llera-Moya, Y. Ji, N. Wang, M. C. Phillips, J. B. Swaney, A. R. Tall, and G. H. Rothblat. 1998. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J. Biol. Chem. 273: 5599-5606.
127. Yancey, P. G., J. K. Bielicki, W. J. Johnson, S. Lund-Katz, M. N. Palgunachari, G. M. Anantharamaiah, J. P. Segrest, M. G. Phillips, and G. H. Rothblat. 1995. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34: 7955-7965.
128. 1-HDL and influences efflux of cholesterol into plasma. J. Lipid Res. 38: 1242-1253.
129. Miettinen, H. E., M. Jauhiainen, H. Gylling, S. Ehnholm, A. Palomaki, T. A. Miettinen, and K. Kontula. 1997. Apolipoprotein A-I-Fin (Leu159Arg) mutation affects lecithin-cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts. Arterioscler. Thromb. Vasc. Biol. 17: 3021-3032.
130. Milano. Accelerated binding and dissociation from lipids of a human apolipoprotein variant. J. Biol. Chem. 260: 16321-16325.
131. Milano dimer. Biochemistry. 38: 16307-16314.
132. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
133. Mendez, A. J., G. M. Anantharamaiah, J. P. Segrest, and J. F. Oram. 1994. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94: 1698-1705.
134. Fielding, C. J., and P. E. Fielding. 1997. Intracellular cholesterol transport. J. Lipid Res. 38: 1503-1521.
135. Rust, S., M. Rosier, H. Funke, J. Real, Z. Amoura, J. C. Piette, J. F. Deleuze, H. B. Brewer, N. Duverger, P. Denefle, and G. Assmann. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22: 352-355.
136. Bodzioch, M., E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, W. E. Kaminski, H. W. Hahmann, K. Oette, G. Rothe, G. Aslanidis, K. J. Lackner, and G. Schmitz. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22: 347-351.
137. Brooks-Wilson, A., M. Marcil, S. M. Clee, L. H. Zhang, K. Roomp, M. van Dam, L. Yu, G. Brewer, J. A. Collins, H. O. Molhuizen, O. Loubser, B. F. Ouelette, K. Fichter, K. J. Ashbourne-Excoffon, C. W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J. J. Kastelein, and M. R. Hayden. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22: 336-345.
138. Lawn, R. M., D. P. Wade, M. R. Garvin, X. Wang, K. Schwartz, J. G. Porter, J. J. Seilhamer, A. M. Vaughan, and J. F. Oram. 1999. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104: R25-R31.
139. Remaley, A. T., S. Rust, M. Rosier, C. Knapper, L. Naudin, C. Broccardo, K. M. Peterson, C. Koch, I. Arnould, C. Prades, N. Duverger, H. Funke, G. Assman, M. Dinger, M. Dean, G. Chimini, S. Santamarina-Fojo, D. S. Fredrickson, P. Denefle, and H. B. Brewer, Jr. 1999. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original tangier disease kindred. Proc. Natl. Acad. Sci. USA. 96: 12685-12690.
140. Marcil, M., A. Brooks-Wilson, S. M. Clee, K. Roomp, L. H. Zhang, L. Yu, J. A. Collins, M. van Dam, H. O. Molhuizen, O. Loubster, B. F. Ouellette, C. W. Sensen, K. Fichter, S. Mott, M. Denis, B. Boucher, S. Pimstone, J. J. Genest, J. J. Kastelein, and M. R. Hayden. 1999. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet. 354: 1341-1346.
141. Jonas A. 1987. Lecithin cholesterol acyltransferase. In Plasma Lipoproteins. A. M. Gotto, Jr., editor. Elsevier Science Publisher, Amsterdam. 299-333.
142. Jonas, A. 1991. Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim. Biophys. Acta. 1084: 205-220.
143. Jonas, A. 1998. Regulation of lecithin:cholesterol acyltransferase activity. Prog. Lipid Res. 37: 209-234.
144. Fielding, C. J., V. G. Shore, and P. E. Fielding. 1972. A protein cofactor of lecithin:cholesterol acyltransferase. Biochem. Biophys. Res. Commun. 46: 1493-1498.
145. Barter, P. J., G. J. Hopkins, and L. Gorjatschko. 1985. Lipoprotein substrates for plasma cholesterol esterification. Influence of particle size and composition of the high density lipoprotein subfraction 3. Atherosclerosis. 58: 97-107.
146. Bolin, D. J., and A. Jonas. 1994. Binding of lecithin:cholesterol acyltransferase to reconstituted high density lipoproteins is affected by their
147. Bolin, D. J., and A. Jonas. 1996. Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J. Biol. Chem. 271: 19152-19158.
148. Rye, K. A., N. J. Hime, and P. J. Barter. 1996. The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins. J. Biol. Chem. 271: 4243-4250.
149. Sparks, D. L., P. G. Frank, and T. Neville. 1998. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin:cholesterol acyltransferase activity. Biochim. Biophys. Acta. 1390: 160-172.
150. Steinmetz, A., and G. Utermann. 1985. Activation of lecithin:cholesterol acyltransferase by human apolipoprotein A-IV. J. Biol. Chem. 260: 2258-2264.
151. Chen, C. H., and J. J. Albers. 1985. Activation of lecithin:cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma. Biochim. Biophys. Acta. 836: 279-285.
152. Sparrow, J. T., and A. M. Gotto, Jr. 1980. Phospholipid binding studies with synthetic apolipoprotein fragments. Ann. NY. Acad. Sci. 348: 187-211.
153. Yokoyama, S., D. Fukushima, J. P. Kupferberg, F. J. Kezdy, and E. T. Kaiser. 1980. The mechanism of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I and an amphiphilic peptide. J. Biol. Chem. 255: 7333-7339.
154. Ponsin, G., L. Hester, A. M. Gotto, Jr., H. J. Pownall, and J. T. Sparrow. 1986. Lipid-peptide association and activation of lecithin:cholesterol acyltransferase. Effect of alpha-helicity. J. Biol. Chem. 261: 9202-9205.
155. Anantharamaiah, G. M., Y. V. Venkatachalapathi, C. G. Brouillette, and J. P. Segrest. 1990. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I. Arterioclerosis. 10: 95-105.
156. Meng, Q. H., L. Calabresi, J. C. Fruchart, and Y. L. Marcel. 1993. Apolipoprotein A-I domains involved in the activation of lecithin:cholesterol acyltransferase. Importance of the central domain. J. Biol. Chem. 258: 16966-16973.
157. Minnich, A., X. Collet, A. Roghani, C. Cladaras, R. L. Hamilton, C. J. Fielding, and V. I. Zannis. 1992. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding. J. Biol. Chem. 267: 16553-16560.
158. Sorci-Thomas, M., M. W. Kearns, and J. P. Lee. 1993. Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation. Structure:function relationships. J. Biol. Chem. 268: 21403-21409.
159. Holvoet, P., Z. A. Zhao, B. Vanloo, R. Vos, E. Deridder, A. Dhoest, J. Taveirne, E. Brouwers, E. Demarsin, Y. Engelborghs, M. Rosseneu, D. Collen, and R. Brasseur. 1995. Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants. Biochemistry. 34: 13334-13342.
160. 166 paired helix of apolipoprotein A-I in lecithin:cholesterol acyltransferase activation. J. Biol. Chem. 272: 15967-15972.
161. Sorci-Thomas, M. G., L. Curtiss, J. S. Parks, M. J. Thomas, and M. W. Kearns. 1997. Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin:cholesterol acyltransferase reactivity. J. Biol. Chem. 272: 7278-7284.
162. Banka, C. L., D. J. Bonnet, A. S. Black, R. S. Smith, and L. K. Curtiss. 1991. Localization of an apolipoprotein A-I epitope critical for activation of lecithin-cholesterol acyltransferase. J. Biol. Chem. 266: 23886-23892.
163. Sorci-Thomas, M. G., L. Curtiss, J. S. Parks, M. J. Thomas, M. W. Kearns, and M. Landrum. 1998. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation. J. Biol. Chem. 273: 11776-11782.
164. Wang, J., J. A. DeLozier, A. K. Gebre, P. J. Dolphin, and J. S. Parks. 1998. Role of glutamic acid residues 154, 155, and 165 of lecithin:cholesterol acyltransferase in cholesterol esterification and phospholipase A2 activities. J. Lipid Res. 39: 51-58.
165. Milano. Atherosclerosis. 128: 121-128.
166. Sparks, D. L., W. S. Davidson, S. Lund-Katz, and M. C. Phillips. 1993. Effect of cholesterol on the charge and structure of apolipoprotein A-I in recombinant high density lipoprotein particles. J. Biol. Chem. 268: 23250-23257.
167. Davidson, W. S., D. L. Sparks, S. Lund-Katz, and M. C. Phillips. 1994. The molecular basis for the difference in charge between pre-β- and α-migrating high density lipoproteins. J. Biol. Chem. 269: 8959-8965.
168. Sparks, D. L., W. S. Davidson, S. Lund-Katz, and M. C. Phillips. 1995. Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability. J. Biol. Chem. 270: 26910-26917.
169. Forte, T. M., J. K. Bielicki, R. Goth-Goldstein, J. Selmek, and M. R. McCall. 1995. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J. Lipid Res. 36: 148-157.
170. Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL, cholesterol, corneal opacifications, and coronary heart disease. Circulation. 94: 1622-1628.
171. Kozyraki, R., J. Fyfe, M. Kristiansen, C. Gerdes, C. Jacobsen, S. Cui, E. I. Christensen, M. Aminoff, A. de la Chapelle, R. Krahe, P. J. Verroust, and S. K. Moestrup. 1999. The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Nat. Med. 5: 656-661.
172. Von Eckardstein, A., H. Funke, A. Henke, K. Altland, A. Benninghoven, and G. Assmann. 1989. Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I. J. Clin. Invest. 84: 1722-1730.
173. Menzel, H. J., G. Assmann, S. C. J. Rall, K. H. Weisgraber, and R. W. Mahley. 1984. Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Munster-3 type. J. Biol. Chem. 259: 3070-3076.
174. 10(Leu), a new ApoAI variant. Hum. Genet. 84: 439-445.
175. Takada, Y., J. Sasaki, M. Seki, S. Ogata, Y. Teranishi, and K. Arakawa. 1991. Characterization of a new human apolipoprotein A-I Yame by direct sequencing of polymerase chain reaction-amplified DNA. J. Lipid Res. 32: 1275-1280.
176. Nichols, W. C., F. E. Dwulet, J. Liepnieks, and M. D. Benson. 1988. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem. Biophys. Res. Commun. 156: 762-768.
177. Matsunaga, T., Y. Hiasa, H. Yanagi, T. Maeda, N. Hattori, K. Yamakawa, Y. Yamanouchi, I. Tanaka, T. Obara, and H. Hamaguchi. 1991. Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene. Proc. Natl. Acad. Sci. USA. 88: 2793-2797.
178. Booth, D. R., S. Y. Tan, S. E. Booth, J. J. Hsuan, N. F. Totty, O. Nguyen, T. Hutton, D. M. Vigushin, G. A. Tennent, W. L. Hutchinson, N. Thomson, A. K. Soutar, P. N. Hawkins, and M. B. Pepys. 1995. A new apolipoprotein AI variant, Trp50Arg, causes hereditary amyloidosis. Q. J. Med. 88: 695-702.
179. Soutar, A. K., P. N. Hawkins, D. M. Vigushin, G. A. Tennent, S. E. Booth, T. Hutton, O. Nguyen, N. F. Totty, T. G. Feest, and J. J. Hsuan. 1992. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. Proc. Natl. Acad. Sci. USA. 89: 7389-7393.
180. Booth, D. R., S. Y. Tan, S. E. Booth, G. A. Tennent, W. L. Hutchinson, J. J. Hsuan, N. F. Totty, O. Truong, A. K. Soutar, P. N. Hawkins, M. Bruguera, J. Caballeria, M. Solé, J. M. Campistol, and M. B. Pepys. 1996. Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene. J. Clin. Invest. 97: 2714-2721.
181. Persey, M. R., D. R. Booth, S. E. Booth, R. van Zyl-Smit, B. K. Adams, A. B. Fattaar, G. A. Tennent, P. N. Hawkins, and M. B. Pepys. 1998. Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I. Kidney Int. 53: 276-281.
182. Hamidi, A. L., J. J. Liepnieks, A. K. Hamidi, T. Uemichi, G. Moulin, E. Desjoyaux, R. Loire, M. Delpech, G. Grateau, and M. D. Benson. 1999. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein AI. Am. J. Pathol. 154: 221-227.
183. Araki, K., J. Sasaki, A. Matsunaga, Y. Takada, K. Moriyama, K. Hidaka, and K. Arakawa. 1994. Characterization of two new human apolipoprotein A-I variants: apolipoprotein A-I Tsushima (Trp-108→Arg) and A-I Hita (Ala-95(Asp). Biochim. Biophys. Acta. 1214: 272-278.
184. Moriyama, K., J. Sasaki, A. Matsunaga, Y. Takada, M. Kagimoto, and K. Arakawa. 1996. Identification of two apolipoprotein variants, A-I Karatsu (Tyr 100(His) and A-I Kurume (His 162(Glu). Clin. Genet. 49: 79-84.
185. Rall, S. C., Jr., K. H. Weisgraber, R. W. Mahley, Y. Ogawa, C. J. Fielding, G. Utermann, J. Haas, A. Steinmetz, H. J. Menzel, and G. Assmann. 1984. Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted. J. Biol. Chem. 259: 10063-10070.
186. Jonas, A., A. Von Eckardstein, L. Churgay, W. W. Mantulin, and G. Assmann. 1993. Structural and functional properties of natural and chemical variants of apolipoprotein A-I. Biochim. Biophys. Acta. 1166: 202-210.
187. 107(0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency. Arterioscler. Thromb. Vasc. Biol. 15: 1294-1306.
188. Von Eckardstein, A., H. Funke, M. Walter, K. Altland, A. Benninghoven, and G. Assmann. 1990. Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure. J. Biol. Chem. 265: 8610-8617.
189. Takada, Y., J. Sasaki, S. Ogata, T. Nakanishi, Y. Ikehara, and K. Arakawa. 1990. Isolation and characterization of human apolipoprotein A-I Fukuoka (110Glu(-Lys). A novel apolipoprotein variant. Biochim. Biophys. Acta. 1043: 169-176.
190. Rall, S. C., Jr., K. H. Weisgraber, R. W. Mahley, C. Ehnholm, O. Schamaun, B. Olaisen, J. P. Blomhoff, and P. Teisberg. 1986. Identification of homozygosity for a human apolipoprotein A-I variant. J. Lipid Res. 27: 436-441.
191. Utermann, G., J. Haas, A. Steinmetz, R. Paetzold, S. C., Rall, Jr., K. H. Weisgraber, and R. W. Mahley. 1984. Apolipoprotein A-IGiessen (Pro143(Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase. Eur. J. Biochem. 144: 325-331.
192. Deeb, S. S., M. C. Cheung, R. Peng, A. C. Wolf, R. Stern, J. J. Albers, and R. H. Knopp. 1991. A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins. J. Biol. Chem. 266: 13654-13660.
193. Huang, W., J. Sasaki, A. Matsunaga, H. Nanimatsu, K. Moriyama, H. Han, M. Kugi, T. Koga, K. Yamaguchi, and K. Arakawa. 1998. A novel homozygous missense mutation in the apoA-I gene with apoA-I deficiency. Arterioscler. Thromb. Vasc. Biol. 18: 389-396.
194. Mahley, R. W., T. L. Innerarity, S. C. Rall, Jr., and K. H. Weisgraber. 1984. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25: 1277-1294.
195. Fin - Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene. Arterioscler. Thromb. Vasc. Biol. 17: 83-90.
196. Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I. J. Lipid Res. 38: 121-131.
197. Hamidi, A. K., J. J. Liepnieks, M. Nakamura, F. Parker, and M. D. Benson. 1999. A novel apolipoprotein A-I variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis. Biochem. Biophys. Res. Commun. 257: 584-588.
198. Polites, H. G., G. W. Melchior, C. K. Castle, and K. R. Marotti. 1986. The primary structure of cynomolgus monkey apolipoprotein A-I deduced from the cDNA sequence: comparison to the human sequence. Gene. 49: 103-110.
199. Chung, H., A. Randolph, I. Reardon, and R. L. Heinrikson. 1982. The covalent structure of apolipoprotein A-I from canine high density lipoproteins. J. Biol. Chem. 257: 2961-2967.
200. Birchbauer, A., G. Knipping, B. Juritsch, H. Aschauer, and R. Zechner. 1993. Characterization of the apolipoprotein AI and CIII genes in the domestic pig. Genomics. 15: 643-652.
201. Pan, T. C., Q. L. Hao, T. T. Yamin, P. H. Dai, B. S. Chen, S. L. Chen, P. A. Kroon, and Y. S. Chao. 1987. Rabbit apolipoprotein A-I mRNA and gene. Evidence that rabbit apolipoprotein A-I is synthesized in the intestine but not in the liver. Eur. J. Biochem. 170: 99-104.
202. O'hUigin, C., L. Chan, and W. H. Li. 1990. Cloning and sequencing of bovine apolipoprotein A-I cDNA and molecular evolution of apolipoproteins A-I and B-100. Mol. Biol. Evol. 7: 327-339.
203. Sparrow, D. A., P. M. Laplaud, M. Saboureau, G. Zhou, P. J. Dolphin, A. M. Gotto, Jr., and J. T. Sparrow. 1995. Plasma lipid transport in the hedgehog: partial characterization of structure and function of apolipoprotein A-I. J. Lipid Res. 36: 485-495.
204. Stoffel, W., R. Muller, E. Binczek, and K. Hofmann. 1992. Mouse apolipoprotein AI. cDNA-derived primary structure, gene organisation and complete nucleotide sequence. Biol. Chem. Hoppe Seyler 373: 187-193.
205. Poncin, J. E., J. A. Martial, and J. E. Gielen. 1984. Cloning and structure analysis of the rat apolipoprotein A-I cDNA. Eur. J. Biochem. 140: 493-498.
206. Byrnes, L., C. C. Luo, W. H. Li, C. Y. Yang, and L. Chan. 1987. Chicken apolipoprotein A-I: cDNA sequence, tissue expression and evolution. Biochem. Biophys. Res. Commun. 148: 485-492.
207. Powell, R., D. G. Higgins, J. Wolff, L. Byrnes, M. Stack, P. M. Sharp, and F. Gannon. 1991. The salmon gene encoding apolipoprotein A-I: cDNA sequence, tissue expression and evolution. Gene. 104: 155-161.